Cargando…

Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer

BACKGROUND: Cancer-associated fibroblasts (CAFs) are some of the most abundant components of the tumour microenvironment. A recent study suggested that in some cancers, CAFs express programmed death ligand 1 (PD-L1), which can act as a prognostic marker. The aim of this study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshikawa, Katsuhiro, Ishida, Mitsuaki, Yanai, Hirotsugu, Tsuta, Koji, Sekimoto, Mitsugu, Sugie, Tomoharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937297/ https://www.ncbi.nlm.nih.gov/pubmed/33676425 http://dx.doi.org/10.1186/s12885-021-07970-x

Ejemplares similares

Prognostic significance of adipophilin expression in biopsy specimens of patients with triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Association between fatty acid synthase and adipophilin expression in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2020)

Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study
por: Yanai, Hirotsugu, et al.
Publicado: (2021)

Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2020)

Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast
por: Yanai, Hirotsugu, et al.
Publicado: (2022)

Intramural bronchogenic cysts of the esophagus and gastroesophageal junction: A case report
por: Matsuda, Hayato, et al.
Publicado: (2020)

Significance of desmoplastic reactions on tumor deposits in patients with colorectal cancer
por: Kobayashi, Toshinori, et al.
Publicado: (2022)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
por: Kobayashi, Toshinori, et al.
Publicado: (2023)

Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer
por: Shi, Shuai, et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective study
por: Kosaka, Hisashi, et al.
Publicado: (2022)

Prognostic significance of GSTP1 in patients with triple negative breast cancer
por: Chen, Guanglei, et al.
Publicado: (2017)

Expression and Prognostic Significance of BANF1 in Triple-Negative Breast Cancer
por: Zhang, Genhao
Publicado: (2020)

Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
por: Cao, Jintao, et al.
Publicado: (2021)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
por: Čeprnja, Toni, et al.
Publicado: (2022)

Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer
por: Takai, Ken, et al.
Publicado: (2016)

Usefulness and problems of cytological examination by endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal lymphadenopathy: A retrospective single-centre study
por: Sandoh, Kaori, et al.
Publicado: (2021)

PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
por: Alkaabi, Duaa, et al.
Publicado: (2023)

Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
por: Yu, Tianjian, et al.
Publicado: (2017)

Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
por: Liu, Jingxin, et al.
Publicado: (2019)

Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab
por: Yoshida, Terufumi, et al.
Publicado: (2021)

Significance of E-cadherin expression in triple-negative breast cancer
por: Kashiwagi, S, et al.
Publicado: (2010)

Clinical significance of morphologic characteristics in triple negative breast cancer
por: Ryu, Dong Won, et al.
Publicado: (2011)

Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells
por: Wang, Mengchuan, et al.
Publicado: (2017)

Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer
por: Wei, Wei, et al.
Publicado: (2020)

Immunotherapy Targeting PD-1/PD-L1 in Early-Stage Triple-Negative Breast Cancer
por: Yang, Tinglin, et al.
Publicado: (2023)

Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
por: Tashireva, Liubov A., et al.
Publicado: (2023)

The risk of PD-L1 expression misclassification in triple-negative breast cancer
por: Ben Dori, Shani, et al.
Publicado: (2022)

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer
por: Cubukcu, Erdem, et al.
Publicado: (2014)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium
por: Ebisu, Yusuke, et al.
Publicado: (2020)

Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion
por: Noda, Yuri, et al.
Publicado: (2022)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers
por: Barrett, Michael T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u2vjn965c6sdl1su3ijbnfukts